The Quiet Revolution in Health Care and Health Product Regulation
This article was originally published in RPM Report
Executive Summary
Compliance is taking on a new meaning for Big Pharma, one that de-emphasizes traditional government oversight in favor of novel, consumer-focused quality measures. The Medicare Part D program is helping to drive the change.
You may also be interested in...
Improvements in Preventive Care Lacking
The push to improve healthcare quality in the U.S. has been a consistent goal, imbedded in the industry for years. However, over the last decade this movement rose to a higher level of necessity, and a number of programs have been generated from within the industry as well as government agencies -- but, has significant progress been made?